IDH2 p.R172M
About
Gene context: IDH2
Biomarker Type: Somatic Variant
Present: True
Chromosome: 15
Start Position: 90631838
End Position: 90631838
Reference Allele: C
Alternate Allele: A
Cdna Change: c.515G>T
Protein Change: p.R172M
Variant Annotation: Missense
Exon: 4
Rsid: rs121913503
Hgvsg: 15:g.90631838C>A
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | IDH2 p.R172M | Acute Myeloid Leukemia | Enasidenib | |
| EMA (1) FDA (1) | IDH2 p.R172M | Astrocytoma | Vorasidenib | |
| EMA (1) FDA (1) | IDH2 p.R172M | Oligodendroglioma | Vorasidenib |